Back to search
Non-hypovolemic Non-acute Hyponatremia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Non-hypovolemic Non-acute Hyponatremia trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Non-hypovolemic Non-acute Hyponatremia trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a randomized, double-blind, multicenter, placebo-controlled (standard therapy + placebo), phase 2 efficacy and safety study of the Tolvaptan tablets in…
This drug has been developed to treat Hyponatremia. The primary purpose of this study is to verify the efficacy and safety of seven-day repeated oral administra…